# LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

Study · id `cardio:ct-nct01628159` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01628159](<https://clinicaltrials.gov/study/NCT01628159>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01628159

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 657 participants.

## Technical summary

Registry record NCT01628159. Allocation not applicable; no masking; primary purpose treatment. Start 2012-06 (registry gives no type); primary completion 2018-09 (actual). Results posted on 2020-04-10.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 657 participants (enrolled count; ClinicalTrials.gov record NCT01628159, source copy `cardio:ctgov-nct01628159-2020-04-10`, retrieved 2026-10-31)
- Start date: 2012-06 (registry gives no type) (ClinicalTrials.gov record NCT01628159, source copy `cardio:ctgov-nct01628159-2020-04-10`, retrieved 2026-10-31)
- Primary completion: 2018-09 (actual) (ClinicalTrials.gov record NCT01628159, source copy `cardio:ctgov-nct01628159-2020-04-10`, retrieved 2026-10-31)
- Completion: 2018-12 (actual) (ClinicalTrials.gov record NCT01628159, source copy `cardio:ctgov-nct01628159-2020-04-10`, retrieved 2026-10-31)
- Results first posted: 2020-04-10 (ClinicalTrials.gov record NCT01628159, source copy `cardio:ctgov-nct01628159-2020-04-10`, retrieved 2026-10-31)
- Countries: United States; Austria; Belgium; Germany; Switzerland (ClinicalTrials.gov record NCT01628159, source copy `cardio:ctgov-nct01628159-2020-04-10`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01628159-2020-04-10`, retrieved 2026-10-31)

## The registry's words

- Brief title: LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)
- Condition: Peripheral Artery Disease
- Intervention (Device): Lutonix Drug Coated Balloon
- Lead sponsor: C. R. Bard
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: C. R. Bard (`cardio:org-c-r-bard`)

## Provenance

Content hash: 2d0b2ec3aa354fe8c7acb0447d12504d2c62b448c89788c0a86264e957f64641
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
